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ABSTRACT 
The effect of prenatal injections of adreno-
corticotropin and glucocorticoid on glucose-6-phosphate 
dehydrogenase and glycogen in neonatal rat liver. 
Glycogen and_ glucose-6-phosphate dehydrogenas·e 
(G6PD) levels were assayed in the livers of neonatal rats 
whose mothers were injected during gestation with 
adrenocorticotropin {ACTH) or a synthetic glucocorticoid, 
dexamethasone. Four to six newborn pups were selected 
randomly and sacrificed within 12 hours of birth. Body 
weights and liver glycogen levels were significantly 
decreased in neonatal rats subjected to maternal injections 
of dexamethasone when compared to saline injected controls. 
ACTH injections did not cause significant differences 
from controls in body weights and glycogen levels. 
Dexamethasone injections caused a slight decrease in 
G6PD, but all treatments showed insignificant differences. 
It is concluded that maternal glucocorticoids in the 
doses used (800 µg/day), cross the placental tissues 
and inversely affect the enzymes of the glycogenic and 
_ glycogenolytic pathways. ACTH in the dose used .(:i I. U ./day 
was_not affective in eliciting this response through 
maternal adrenal activation. 
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INTRODUCTION 
Claude Bernard (1859) demonstrated that glycogen is 
stored in the fetal liver at a stage in gestation that is 
characteristic of each species. The glycogen content of 
the rat fetal liver increases greatly during the last few 
days of gestation (Bernard, 1859). Jacquot and 
Kretchmer (1964) determined that the change in glycogen 
content in the rat fetal liver progresses gradually 
between gestational days 15 and 18, and increases sharply 
between 19 and 20 days of gestation. 
Endocrine stimulation of glycogen deposition has 
been suggested in numerous studies. Jacquot and Kretchmer 
(1964) indicated that the increase in glycogen deposition 
in the rat is dependent upon hormonal stimulation and 
does not occur when the fetus is deprived of adrenal 
corticosteroids before day 19 of gestation. Experiments 
•in ·utero have shown that adrenal corticosteroids can 
increase glycogen in fetal liver as early as the 15th day 
of gestation (Greengard and Dewey, 1970). The action of 
adrenal corticoids in promoting deposition of glycogen in 
the rat liver has also been documented by Wintenitz et al 
(1957). Jost (1961) and Jacquot (1959) indicated that the. 
glycogen accumulation during gestati-0n-is dependent on the 
presence of both adrenal and pituitary or placental factors. 
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There is a direct relationship between patterns of 
enzymatic activities during devleopment and accumulation 
of glycogen in the intact rat fetus (Jacquot and 
2 
Kretchmer, 1964). Eisen et al (1973) proposed the 
hypothesis that liver glycogen synthesis during the last 
trimester requires both glucocorticoids and insulin for 
the activation of glycogen synthetase. Enzymatic 
mechanisms involved in glucocorticoid induced glycogen 
deposition have been proposed by Baxter and Forsham (1973). 
These mechanisms _are illustrated in Figure 1. 
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Figure 1. Simpl:ified diagram of the scheme of the reactions 
in glycogen formation and breakdown showing 
stimulatory(+) and inhibitory (-) effects of 
cyclic AMP, Insulin, Glucocorticoids and Glucose. 
G-1-P = Glucose-1-phosphate. UDPG = Glycogen 
phosphorylase a. (Baxter and Forsham, 1972). 
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Glucocorticoids activate glycogen synthetase through 
activation of glycogen synthetase phosphatase, an enzyme 
which removes phosphate from the inactive glycogen 
synthetase. This dephosphorylation activates the enzyme 
glycogen synthetase. Additionally, high glucose levels 
activate glycogen synthetase through insulin stimulation 
and directly inhibit the glycolytic enzyme, phosphorylase a. 
Jacquot and Kretchmer (1964) determined the activities 
of liver enzymes important in glycogen metabolism from 
intact fetal rats as well as from fetal rats deprived of 
corticoids by decapitation in utero. They found that 
storage of glycogen in liver of fetal rats seems to be 
related to the relative inactivity of ·glucose-6-phosphate 
(G6P), until almost term. During the same time, the 
glycogenic enzyme, glycogen synthetase, increases its 
activity. The major increase in gl~cogen synthetase 
concentration and activity was found to occur between the 
17th and 19th days-of gestation (Jacquot and Kretchmer 
(1964). They found that hepatic glucose-6-phosphate 
dehydrogenase (G6PD) steadily decreased in activity so 
that at 21 days of gestation, it was half the value 
observed at 18 days of gestation. Thus, an apparent 
inverse relationship was suggested between the levels of 
glycolytic enzymes and those enzymes of the glycogenic 
pathway (Eisen et al, 1973; Jacquot and Kretchmer, 1964). 
4 
This observation is shown in Figure 2 which shows the 
relationship glycogen deposition and the level of G6PD 
in fetal rat liver. It shows that as the level of G6PD 
falls, the glycogen content rises. 
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phosphate dehydrogenase and concentration in_ 
liver of fetal rat. Glycogen: bars; glucose-
6-phosphate dehydrogenase x x. (Modified 
from Jacquot and Kretchmer, 1964). 
• 
5 
Figure 3 shows levels of G6PD in fetal rat livers of 
unoperated controls and decapitated fetuses (Jacquot and 
Kretchmer, 1964). It is apparent that rats decapitated 
in utero have increased G6PD levels over controls. 
Jacquot and Kretcfuner (1964) suggest that decapitation 
~n utero has the effect of preventing further differ-
entiation of the pathway £or glycogen metabolism . 
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17 18 19 20 21 
Gestational Age (Days) 
Effect of decapitation in utero .on activity 
of glucose-6-phosphate dehydrogenase in 
fetal rat liver. Decapitated rats, it x; 
Controls o----o. (Jacquot and Kretchmer, 
1964). 
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Glucose-6-phosphate dehydrogenase was discovered by 
Warburg in 1931. It has been shown that G6PD activity is 
inhibited by the RNA transcriptional inhibitor actinomycin 
D and the protein translational inhibitor cycloheximide 
(Keran and Barker, 1976). The pentose phosphate pathway 
begins with the dehydrogenation of G6P by nicotinamide 
adenine dinucleotide phosphate (NADP) at carbon one (c-1), 
a reaction catalyzed by G6PD (Stryer, 1975). G6PD has 
proved to be highly specific for NADP+ (Stryer, 1975). 
The reaction catalyzed by G6PD is presented as follows: 
NADP+ NADPH+H+ 
G-6-P-\...--°"----""""'/ _____ ) 6-Phosphoglucono-o-lactone 
-_-G-6:-PD 
G6PD mediates this reaction which is competitive to 
glycogenesis (Eisen _et al, 1973). G6PD catalyzed 
oxidation of G-6-P is important for generating NADPH, a 
hydrogen donor in liver biosynthesis pathways (Rouiller, 
1964). Pyridine linked dehydrogenases are evaluated by 
determining the optical density change as NADP+ is 
reduced. Therefore the change in optical density as 
G6PD reduces NADP+ is used to measure the concentration 
of G6PD in the liver (Kaplan, 1966). 
According to Jost and Tavernie_r (1956), the 
-embryological development of the anterior pituitary 
begins around 14.5 days of gestation in the rat fetus. 
The general shape of the anterior pituitary is well 
outlined by 16 to 17 days of gestation (Jost and 
Tavernier, 1956).. Thus, it is probable that ACTH 
secretion starts after day 15 of gestation in the rat 
fetus. ACTH maintains the structure and enzyme activity 
of the adrenal cortex (Mostafapour and Tchen, 1971). 
Mostafapour and Tchen (1971) showed that ACTH stimulates 
the rat zona fasciculata and zona reticularis to pr.educe 
. glucocorticoids. They showed that.the primary 
glucocorticoid produced is corticosterone. Sugihara and 
Hajime "(1977) and Mazzocchi.et al (1976) showed that the 
corticosterone is produced by the zona :fasciculata, and 
tha_t the· increase .of_ certic9sterone :im the blood is 
~t.rectly related to ACTH levels. Glucocorticoids, in 
turn, regulate ACTH release by a negative feedbac~ 
mechanism.through the pypothalamus. Thus plasma 
corticosterone levels are increased by ACTH injections 
and decreased by exogenous glucocorticoid injections. 
Normally, ACTH itself does not cross the placenta, 
diminishing the likelihood of direct effects on the 
fetus (Milkovic et al, 1966). Milkovic et al (1973) 
have pointed out that adrenal corticosterone of 
J 
maternal ori.gin and controlled by maternal ACTH crosses 
th.e placenta and causes the effects on the fetal rat 
liver. Dexamethasone, a fluoronated synthetic 
glucocorticoid (Figure 4), when injected into pregnant 
rats, reduces maternal ACTH secretion and simultaneously 
lowers blood-ACTH levels in rat fetuses (Sugihara and 
Hajime, 1977). 
Dexarnetl,asone Corticosterone 
Figure 4. The· structures of dexamethasone and 
corticosterone. 
Clearly, the above facts prove that injections of 
ACTH and glucocorticoids to pregnant rats after the 14th 
day of gestation or removal of these endogenous hormones 
may influence fetal glycogen development. In view of 
the fact that effects of prenatal stress were mediated 
by the maternal pi•tuitary-adrenocortical system 
(Smith et al, 1975), the effects of both ACTH and 
. glucocorticoids should be expressed in the offspring. 
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Joffe (1977) found that ACTH did not affect birth weights 
while dexamethasone injections produced a slight decrease 
in birth weights. 
The following study is an attempt to elaborate the 
influence of G6PD and glucocorticoids on glycogen 
deposition in the liver. The effects of maternal 
injections of ACTH and dexamethasone on the levels of 
glycogen and G6PD in the liver of newborn rat pups was 
studied. 
MATERIALS AND METHODS 
Animal Care and Tissue Preparation 
Male and female rats of the Sprague-Dawley strain 
(Harlan Industries, Inc.) were housed under a lighting 
regimen of 12 hours light and 12 hours dark. They were 
given water and Purina Laboratory Chow (Ralston-Purina 
Co.) ad libitum. Tap water was given alternately with 
an antibiotic drinking solution (Sulmet Drinking Solution, 
American Cyanamid Co.). The dosage of the antibiotic 
drinking solution was 30 ml/3.8 liters of water. 
Pregnant rats were obtained by placing one male in 
a cage with. three females. Vaginal smears were taken 
each morning and the presence of sperm in the vagina was 
used as the indicator for pregnancy. The day sperm were 
observed in the vaginal smears was taken as the first day 
of pregnancy (day 1). Pregnant females were hou_sed 
individually. The pregnant rats were divided in three 
groups: 
1. Group one received 5 I.U/0.5 ml/day of ACTH 
(Armour). 
2. Group two received 800 µg/0.2 cc/day of 
Dexamethasone Sodium Phosphate (Dell 
Laboratories, Inc.). 
3. Group three received 0.2 ml of 0.9% NaCl/day. 
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All injections were given intramuscularly, ·.beginning on 
day 15 of gestation and ending at parturition (day 22). 
All analyses were performed within twelve (12) 
hours after birth. Four to six pups were.taken 
randomly from each litter ,.;ind sexed. The pups were 
weighed in a preweighed beaker on a Sartorius Balance 
(Sartorius Balances, Type 2492). Each rat was killed 
by decapitation and exsanguated. The liver was exposed, 
removed with scissor~and blotted before placing on an 
ice block. Each _liver was cut into halves. One liver 
half was added to a preweighed 15 ml round bottom test 
tube containing 3 ml of potassium hydroxide (KOH) prior 
to glycogen determination. The other half was added to 
a 15 ml cold homogenizer and washed in 5 ml of 
homogenizing media (Physiological Saline + 6. 6 x 10-4 M 
EDTA; 25 mg EDTA-Na2 to 100 ml H2 0. Then it was 
homogenized for 2 minutes in 2 ml of iced homogenizing 
media using a Potter-]!:lvehjem Homogenizer. The 
homogenate-was decanted into a cold plastic centrifuge 
tube. The homogenizer was rinsed with 2 ml homogenizing 
media which was added to original homogenate. The 
homogenate was centrifuged for 20 minutes at 1°C at 
15000 r.p.m. in a Model B~20 International Refrigerated 
Centrifuge (International· ·Equipment Co.). After 
centrifuging, ·.the supernatant was decanted into disposable 
11 
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test tubes (Lancer 12 x 75 mm Disposable Tube Polystyrene) 
and kept on ice until assayed for G6PD. 
G6PD Assay 
G6PD was assayed with a Beckman DU-2 Spectrophotometer 
(Beckman Instruments, Inc.) using the procedure of Lohr and 
Waller. Into each 3 ml Beckman cuvette, 2.4 ml 
triethanolamine buffer (Sigma Chemical Co.); 0.5 ml 
-2 . NADPH [3·x 10- M (25 mg NADPH in 1 ml 1% NaHCO 3 )]; and 2 2 
0.5 ml of the supernatant was added. Each cuvette 
contained supernatant from a different pup. Then 0.05 ml 
glucose-6-phosphate [4 x 10- 2M (130 mg G6P-Na 2 in 10 ml 
H2 O) (Sigma Chemical Co.)l was added to each cuvette, and 
mixed quickly with the other reagents. Optical density 
(O.D.) readings were taken each minute for 10 minutes using 
a wide slit width and a wavelength of 340 mµ. The 
average optical density (O.D.) change per minute was 
calculated from these 10 readings. The following 
formuia was used to calculate the G6P-D units/ml serum: 
llE 3 40 /min 
0.001 
= (llE 340 /min) x 1000 x dilution factor (2) 
= G6P-D units/ml serum 
~his formula is used with 1 ml supernatant in a 3 ml 
assay mixture. The usual definition of 1 unit of enzyme 
activity according to the J.S. LaDue et al (1954) is the 
amount of enzyme in 1 ml sample, which at 25°C in a 3 ml 
assay mixture,, changes the optical density of NADP at 
340 mµ by 0. 001 in l min. 
Glycogen· As·say 
13 
The determination of glycogen was by the Anthrone 
Reagent Method (Carroll et al, 1956). The liver half 
in the test tube with 3 ml of KOH was digested in a 
boiling water bath for 20-30 minutes. The liver digest 
was cooled, and the contents of each test tube were 
transferred quantitatively to a SO ml volumetric flask 
and diluted to SO ml with distilled water. They were 
mixed thoroughly. A 0.4 ml aliquot of the solution 
was finally diluted to 50 ml with distilled water in a 
second 50 ml volumetric flask. A 5 ml aliquot of each 
final dilution was transferred to a 25 ml round-bottom 
test tube. Standards were prepared using 5 ml glucose 
solution (containing 20 µg of glucose per ml), and a 
blank was prepared with 5 ml distilled water. All test 
tubes were put in a cold water bath. Ten milliliters 
of Anthrone Reagent [(0.2µg Anthrone in 100 ml of 95% 
H2SO4) (Fisher Scientific Co.) was pipetted into each 
test tube. The contents were mixed by agitation with 
9" long disposable Pasteur pipettes (Fisher Scientific 
Co.). The cold test tubes were covered with glass 
marbles and heated in a boiling-water bath. At the end 
of 10 minutes , the test tubes were cooled immediate ly 
i n a ice water bath . The absorbancy of each tube was 
read in a Spectronic- 20 Colorimete r (Bausch and Lomb) 
at 620 mµ after the galvanometer had been set at 100 
with the blank . Calculations were made using the 
formula : 
100 XU 
µ g of glycogen in aliquot =1 . 11 x s 
where : u = the optical density of the unknown test 
solution. 
s = the optical density of the 100- µg glucose 
standard . 
1 . 11 = the factor determined by Morris f or the 
conversion of glucose to glycogen , with 
this equation. 
Protein Assay 
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Protein was determined by t h e Lowry Method (1957). 
A 0 . 5 ml aliquot of t he supernatant from the G6PD assay 
was transferred t o plastic centrifuge tubes and an 
equal vol ume of 10% trichloroacetic acid (TCA) was 
added to precipitate the p r oteins . The test tube s were 
centrifJged at 20 , 000 r . p . m. for 10 minutes. The 
supe rnata nt was de canted and discarded . A 0 . 5 ml 
aliquot of 3N sodium hydro xide (NaOH) was added to the 
pelle t and the solution was hydro l yzed in a boiling 
water bath for 15 minutes . 
1-5 
Fifty microliters of each supernatant was put into 
colorimetric tubes. Standards containing O ml; 0.01 ml; 
0.05 ml; 0.1 ml; and 0.2 ml of 1 mg/ml bovine serum 
albumin (BSA) were run parallel to the samples. All 
colorimetric tubes were brought to a volume of 0.5 ml 
with distilled water. A 2.5 ml volume of a color reagent 
(50 ml of 2% NaCO 3 in 0.1 N NaOH + 1 ml of 0.5% cuso~· 
5 H2 0 in 1% of Na+ or K+ tartrate), was mixed with each 
tube and allowed to react for 30 minutes. Then 0.25 ml 
of a 1:1 dilution of commercial Polin and Ciocaltea's 
reagent (Sigma Chemical Co.), was added. Each tube was 
vortexed and allowed to stand for 30 minutes. Absorbancy 
was read using wavelength of 7.50 nm and at constant time 
inter.val with a colorimeter (Spectronic 70 by Bausch and 
Lomb, 1977). A curve was constructed from the standards 
and the samples were read off the curve. Protein 
concentrations were expressed as milligram of protein. 
Statistital Analysis 
Statistical treatment was by analysis of variance 
using the P.05 level. Significance between means was 
evaluated using the Duncan's New Multiple Range Test. 
RESULTS 
The comparative effects of injections of ACTH 
dexamethasone and saline injected controls on neonatal 
body weights is shown in Figure 5. The differences in 
body weight in the three treatments were significant 
as shown by analysis of variance at the P.05 level 
(calculated F=l6.69 > tabulated F=3.15) for 2 and 
57 degrees of freedom. Duncan's New Multiple Range 
Test (Duncan's NMRT) showed a significant decrease in 
neonatal weights of pups of dexamethasone treated rats 
as compared to both those of the ACTH treated and the 
controls. But there was no significant difference 
between ACTH treated and saline injected rats. 
Figure 6 shows the effect of prenatal injections 
of dexamethasone, ACTH, and saline on neonatal amount 
of glycogen in the neonatal rat liver. Analysis of 
variance showed a significant F of 8.34 (tabulated 
F=3.15). Duncan's NMRT showed that the amount of 
glycogen in livers of pups of dexamethasone treated 
' 
mothers is significantly higher than that in livers 
of pups of both ACTH, and saline treated mothers. 
But the difference in amount of glycogen in livers 
of !?UPS of ACTH, and saline treated rats was not 
significant. 
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Both the analysis of variance and Duncan's NMRT 
showed that the differences in the amount of G6PD 
between treatments were insignificant. The analysis 
of variance at the P.05 level showed a nonsignificant 
F of 2.09 (tabulated F=3.15). The effect of prenatal 
injections of dexamethasone, ACTH, and saline on 
neonatal amount of G6PD in rat fetuses is shown in 
Figure 7. 
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Figure 7. The effect of prenatal injections of 
dexamethasone and ACTH, on the neonatal 
amount of G6PD in rats (mean:!:.standard 
deviation). F calculated 2.09 < F tabulated; 
Any two means underscored by the same line 
are not significant. 
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DISCUSSION 
Glucocorticoids have a catabolic effect on many 
of the tissues of the body and an anabolic effect on the 
liver. Thus tissues such as muscle, skin, lymphoid, and 
adipose respond to glucocorticoids by decreased 
synthesis and increased degradation of protein, fat, 
RNA and DNA, and decreased uptake of glucose and amino 
acids (Baxter and Forsham, 1972). In this studY, 
excessive injections of dexamethasone into pregnant rats 
the last trimester of pregnancy demonstrated a significant 
decrease in the body weight of neonatal pups, when 
compared to saline injected controls (Figure 5). The well 
known activation of gluconeogenic pathways and inhibition 
of glucose and amino acid uptake are suggested causes for 
growth inhibition. Figure 5 also shows that maternal 
ACTH injections were not effective on the body weights of 
neonatal pups. This evidence concurs with the research 
of Joffe (1977) which indicated that ACTH did not effect 
birth weights while dexamethasone injections produced a 
slight decrease in birth weights of pups. 
An apparent inverse relationship was suggested 
between the levels of glycolytic enzymes and those of the 
glycogenic pathway (Eisen et al, 1973; Jacquot and 
Kretchmer, 1964). Thus, it was reported that as liver 
22 
_glycogen levels increased from gestational days 17 to 21, 
G6J?D concentration fell {Jacquot and Kretchmer, 1964). 
Although this study did not examine enzymes of the 
glycogenic pathway, glycogen deposition was measured as 
an indicator of glycogen synthetase activity. Glycogen· 
levels were significantly greater in the liver of 
neonatal pups from pregnant dams injected with dexamethasone 
in the last trimester of pregnancy (Figure 6). This effect 
by glucocorticoids substantiates the reported role that 
adrenal corticoids stimulate glycogen deposition by 
activation of glycogen synthetase (Baxter and Forsham, 
1972). Dexamethasone may be more effective in glycogen 
·deposition since it is not metabolized as rapidly as 
endogenous glucocorticoids. 
G6PD levels were not significantly affected by 
dexamethasone injections. This is in contradiction to 
results published by Jacquot and Kretchmer (1964). This 
contradiction may be due to the fact that Jacquot and 
Kretchmer examined the fetuses just before they were born, 
while in the present study the examination was done 
between one and twelve hours after birth. However, the 
correlation that glycogen and G6PD levels are inversely 
related is supported by the results of this study (Figures 
6 and 7). Thu~ the dexamethasone treated rats which 
showed a lower G6PD level than controls (Figure 7), 
23 
inversely showed a significantly higher content of liver 
glycogen. 
Milkovic et al (1966) found that ACTH does not cross 
the placental barrier, thus negating the direct effect of 
ACTH on the fetus. However, ACTH in the maternal plasma 
stimulates maternal adrenal glucorticoid release which 
can cross the placenta to stimulate the fetal rat liver 
(Milkovic et al, 1973). ACTH injections into pregnant 
rats showed a non-significant elevation of neonatal liver 
and glycogen and G6PD from saline injected controls 
(Figure 6 and 7). This insignificant increase may be 
explained by an insufficient dose of ACTH, by the 
·inactivation of ACTH prior to maternal adrenal stimulation, 
or by the inactivation of adrenal corticoids by maternal 
and/or fet~l liver. 
The conclusion of these experiments is that maternal 
injections of dexamethasone,btitnot ACTH, in the doses used, 
significantly depressed body weight and elevated liver 
glycogen, but did not effect liver G6PD levels in newborn 
rats, Therefore, the adrenal cortex of the mother may 
serve as an important regulator of fetal development, 
specifically glycogen deposition. 
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